CFPB cracks down on popular paycheck advance programs. Here’s what that means for workers

CFPB cracks down on popular paycheck advance programs. Here’s what that means for workers


Key Points
  • The Consumer Financial Protection Bureau proposed a rule that would label paycheck advance programs as loans, if users are charged a fee.
  • These programs are sometimes known as earned wage access, daily pay, instant pay, accrued wage access, same-day pay and on-demand pay.
  • Under the proposed rule, users would see fees expressed as an APR, like credit-card interest rates.



Source

Stocks making the biggest moves after hours: Cisco, Flutter Entertainment, Firefly and more
Finance

Stocks making the biggest moves after hours: Cisco, Flutter Entertainment, Firefly and more

Check out the companies making headlines in after-hours trading. Cisco — Shares of Cisco gained more than 7% in extended trading after the networking company posted better-than-expected profit and revenue for its fiscal first quarter. Cisco earned $1 per share, excluding items, on $14.88 billion in revenue, while analysts polled by LSEG expected 98 cents […]

Read More
Boston Fed President Collins advocates holding rates steady, sees ‘high bar’ for further cuts
Finance

Boston Fed President Collins advocates holding rates steady, sees ‘high bar’ for further cuts

Key Points Boston Fed President Susan Collins said she will be reluctant to support further rate cuts anytime soon with inflation still high and policymakers hampered by a lack of data. “I see several reasons to have a relatively high bar for additional easing in the near term,” said Collins, a voter this year on […]

Read More
Stocks making the biggest moves midday: Goldman Sachs, AMD, Oklo, Circle Internet & more
Finance

Stocks making the biggest moves midday: Goldman Sachs, AMD, Oklo, Circle Internet & more

Check out the companies making the biggest moves midday: Alkermes — The biotech company dropped 9% as traders weighed phase 2 trial results for its ALKS 2680 drug, which aims to treat narcolepsy. While the company will be advancing the drug to a Phase 3 trial, a higher range of doses or a split dosing […]

Read More